List of works - Heidar Sharafi

A Simple PCR-RFLP Method for Genotyping of IFNL4 rs368234815 Polymorphism in Patients With Chronic Hepatitis C.

scientific article published on 4 January 2017

A facile PCR-RFLP method for genotyping of ITPA rs1127354 and rs7270101 polymorphisms.

scientific article

Aflatoxin B1 exposure and the risk of hepatocellular carcinoma in Iranian carriers of viral hepatitis B and C

Alanine transaminase as a single marker is not reliable for selecting candidates of pegylated interferon and ribavirin treatment

scientific article published on 20 May 2014

Association of -24CT, 1249GA, and 3972CT ABCC2 Gene Polymorphisms with Methotrexate Serum Levels and Toxic Side Effects in Children with Acute Lymphoblastic Leukemia

article

Association of PNPLA3 rs738409 polymorphism with Liver Steatosis but not with Cirrhosis in Patients with HBV Infection: Systematic Review with Meta-analysis

scientific article published on 7 December 2017

Can serum level of HBsAg differentiate HBeAg-negative chronic hepatitis B from inactive carrier state?

scientific article

Can we include genetic variants with high linkage disequilibrium into a multiple logistic model?

article

Combination of sofosbuvir, pegylated-interferon and ribavirin for treatment of hepatitis C virus genotype 1 infection: a systematic review and meta-analysis

scientific article

Comment on "No impact of interleukin-28B polymorphisms on spontaneous or drug-induced hepatitis delta virus clearance" by Ubaldo Visco-Comandini et al. [Dig. Liver Dis. 2014;46:348-52].

scientific article published on 9 May 2014

Continuum of hepatitis C care cascade in prison and following release in the direct-acting antivirals era

scientific article published on 20 October 2020

Corrigendum to: Comparison of Serum Hepatitis B Virus DNA and HBsAg Levels Between HBeAg-Negative and HBeAg-Positive Chronic Hepatitis B Patients [Published in Jundishapur Journal of Microbiology. 2015 March; 8(3): e21444].

scientific article published on 26 December 2015

Differentiation of hepatitis B/hepatitis D coinfection and superinfection in asymptomatic blood donors: is it possible?

scientific article published in October 2014

Efficacy of Prolonged Treatment With Pegylated Interferon (Peg-IFN) and Ribavirin in Thalassemic Patients With Hepatitis C Who Relapsed After Previous Peg-IFN-Based Therapy.

scientific article

Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study

scientific article published on 27 September 2019

Hepatitis A Virus and Hepatitis E Virus Seroprevalence Among Blood Donors in Tehran, Iran

scientific article published on 23 January 2016

Hepatitis C resistance to NS5A inhibitors: Is it going to be a problem?

scientific article published on 01 September 2018

High Response Rate to Pegylated Interferon Alpha and Ribavirin Combination Therapy in Hemophilic Children with Chronic Hepatitis C; A Case-Control Study

scientific article published on 18 June 2015

How Can the IL28B Polymorphisms with Linkage Disequilibrium Affect the Natural Course of Hepatitis B Inversely?

scientific article published on 24 March 2014

How can we make decision for patients with chronic hepatitis B according to hepatitis B virus (HBV) DNA level?

scientific article published on 05 February 2014

Impact of IFNL4 rs12979860 and rs8099917 polymorphisms on response to Peg-Interferon-α and Ribavirin in patients with congenital bleeding disorder and chronic hepatitis C.

scientific article

Interferon alpha-2b therapy in chronic hepatitis delta

scientific article published on March 2014

Interferon-λ Genetic Variations and Hepatitis C: Yet to be Discovered.

scientific article published on 10 May 2014

Interferon-λ polymorphisms and response to pegylated interferon in Iranian hepatitis C patients

scientific article published in August 2015

Letter: the rs12979860 and ss469415590 polymorphisms of IFNL4 gene are in strong linkage disequilibrium in Caucasian patients with chronic hepatitis C.

scientific article published in February 2014

Molecular Tracing of Hepatitis C Virus Genotype 1 Isolates in Iran: A NS5B Phylogenetic Analysis with Systematic Review

scientific article

Prevalence of hepatitis C virus NS5A resistance-associated substitutions in chronic infection with genotype 1: A pooled analysis based on deposited sequences in GenBank

scientific article published on 25 October 2018

Recommendations for the Clinical Management of Hepatitis C in Iran: A Consensus-Based National Guideline

scientific article

Seroepidemiology and clinical features of hepatitis delta among HBsAg carriers: a study from Hepatitis Clinic of Iranian Blood Transfusion Organization

scientific article published on 18 December 2014

Seroepidemiology of human T-cell lymphotropic virus among Iranian adult thalassemic patients.

scientific article published on August 2014

Seroprevalence of Hepatitis C Virus among Blood Donors in Middle Eastern Countries: A Systematic Review and Meta-Analysis

Serum cytokines, adipokines and ferritin for non-invasive assessment of liver fibrosis in chronic liver disease: a systematic review

scientific article published on 01 April 2019

The high-diagnostic characteristics of HBsAg level in differentiation of hepatitis B clinical presentations: Myth or truth?

scientific article published in October 2016

What is the ethnicity-specific impact of genetic polymorphisms on the response to hepatitis C treatment in an admixed population of Brazilian patients?

scientific article

List of works by Heidar Sharafi

A Simple PCR-RFLP Method for Genotyping of IFNL4 rs368234815 Polymorphism in Patients With Chronic Hepatitis C.

A facile PCR-RFLP method for genotyping of ITPA rs1127354 and rs7270101 polymorphisms.

Aflatoxin B1 exposure and the risk of hepatocellular carcinoma in Iranian carriers of viral hepatitis B and C

Alanine transaminase as a single marker is not reliable for selecting candidates of pegylated interferon and ribavirin treatment

Association of -24CT, 1249GA, and 3972CT ABCC2 Gene Polymorphisms with Methotrexate Serum Levels and Toxic Side Effects in Children with Acute Lymphoblastic Leukemia

Association of PNPLA3 rs738409 polymorphism with Liver Steatosis but not with Cirrhosis in Patients with HBV Infection: Systematic Review with Meta-analysis

Can serum level of HBsAg differentiate HBeAg-negative chronic hepatitis B from inactive carrier state?

Can we include genetic variants with high linkage disequilibrium into a multiple logistic model?

Combination of sofosbuvir, pegylated-interferon and ribavirin for treatment of hepatitis C virus genotype 1 infection: a systematic review and meta-analysis

Comment on "No impact of interleukin-28B polymorphisms on spontaneous or drug-induced hepatitis delta virus clearance" by Ubaldo Visco-Comandini et al. [Dig. Liver Dis. 2014;46:348-52].

Continuum of hepatitis C care cascade in prison and following release in the direct-acting antivirals era

Corrigendum to: Comparison of Serum Hepatitis B Virus DNA and HBsAg Levels Between HBeAg-Negative and HBeAg-Positive Chronic Hepatitis B Patients [Published in Jundishapur Journal of Microbiology. 2015 March; 8(3): e21444].

Differentiation of hepatitis B/hepatitis D coinfection and superinfection in asymptomatic blood donors: is it possible?

Efficacy of Prolonged Treatment With Pegylated Interferon (Peg-IFN) and Ribavirin in Thalassemic Patients With Hepatitis C Who Relapsed After Previous Peg-IFN-Based Therapy.

Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study

Hepatitis A Virus and Hepatitis E Virus Seroprevalence Among Blood Donors in Tehran, Iran

Hepatitis C resistance to NS5A inhibitors: Is it going to be a problem?

High Response Rate to Pegylated Interferon Alpha and Ribavirin Combination Therapy in Hemophilic Children with Chronic Hepatitis C; A Case-Control Study

How Can the IL28B Polymorphisms with Linkage Disequilibrium Affect the Natural Course of Hepatitis B Inversely?

How can we make decision for patients with chronic hepatitis B according to hepatitis B virus (HBV) DNA level?

Impact of IFNL4 rs12979860 and rs8099917 polymorphisms on response to Peg-Interferon-α and Ribavirin in patients with congenital bleeding disorder and chronic hepatitis C.

Interferon alpha-2b therapy in chronic hepatitis delta

Interferon-λ Genetic Variations and Hepatitis C: Yet to be Discovered.

Interferon-λ polymorphisms and response to pegylated interferon in Iranian hepatitis C patients

Letter: the rs12979860 and ss469415590 polymorphisms of IFNL4 gene are in strong linkage disequilibrium in Caucasian patients with chronic hepatitis C.

Molecular Tracing of Hepatitis C Virus Genotype 1 Isolates in Iran: A NS5B Phylogenetic Analysis with Systematic Review

Prevalence of hepatitis C virus NS5A resistance-associated substitutions in chronic infection with genotype 1: A pooled analysis based on deposited sequences in GenBank

Recommendations for the Clinical Management of Hepatitis C in Iran: A Consensus-Based National Guideline

Seroepidemiology and clinical features of hepatitis delta among HBsAg carriers: a study from Hepatitis Clinic of Iranian Blood Transfusion Organization

Seroepidemiology of human T-cell lymphotropic virus among Iranian adult thalassemic patients.

Seroprevalence of Hepatitis C Virus among Blood Donors in Middle Eastern Countries: A Systematic Review and Meta-Analysis

Serum cytokines, adipokines and ferritin for non-invasive assessment of liver fibrosis in chronic liver disease: a systematic review

The high-diagnostic characteristics of HBsAg level in differentiation of hepatitis B clinical presentations: Myth or truth?

What is the ethnicity-specific impact of genetic polymorphisms on the response to hepatitis C treatment in an admixed population of Brazilian patients?